Etesevimab - Research Grade Biosimilar, CAS [[2423948-94-9]], Unconjugated, Monoclonal

Produktübersicht

• Artikelname: Etesevimab - Research Grade Biosimilar, CAS [[2423948-94-9]], Unconjugated, Monoclonal
• Artikelnummer: PRS-21-911
• Hersteller Artikelnummer: 21-911
• Alternativnummer: PRS-21-911-0.1
• Hersteller: ProSci
• Kategorie: Antikörper
• Immunogen: Homo sapiens / SARS-CoV-2 Spike RBD
• Konjugation: Unconjugated
• Alternative Synonym: ANTI-SARS-COV-2 ANTIBODY JS016,CB6 CB-6,ETESEVIMAB,ETESEVIMAB [INN],ETESEVIMAB [USAN],ETESEVIMAB [WHO-DD] IMMUNOGLOBULIN G1 (236-ALANINE,237-ALANINE), ANTI-(SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 SPIKE GLYCOPROTEIN RECEPTOR-BINDING DOMAIN) (HUMAN MONOCLONAL JS016 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL JS016 .KAPPA.-CHAIN, DIMER IMMUNOGLOBULIN G1 (236-ALANINE,237-ALANINE), ANTI-(SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 SPIKE GLYCOPROTEIN) (HUMAN MONOCLONAL LY3832479 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL LY3832479 .KAPPA.-CHAIN, DIMER JS016 JS-016 LY COV016 LY3832479 LY-3832479 LY-COV016 NP005 NP-005, spike glycoprotein

Produkteigenschaften

• Klonalität: Monoclonal
• Konzentration: batch dependent
• NCBI: 43740568
• UniProt: P0DTC2
• Puffer: PBS buffer pH 7.5
• Quelle: CHO cells
• Reinheit: >95%
• CAS Nummer: [2423948-94-9]

Anwendungsbeschreibung

• Application Verdünnung: For research use only .